Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer's disease
Ana Matošević, Dejan Opsenica, Marta Spasić, et al.
Chemico-Biological Interactions (2023) Vol. 382, pp. 110620-110620
Closed Access | Times Cited: 11

Showing 11 citing articles:

A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease
Chandni Pathak, Uma D. Kabra
Bioorganic Chemistry (2024) Vol. 144, pp. 107152-107152
Closed Access | Times Cited: 34
Fused thiophene as a privileged scaffold: A review on anti-Alzheimer's disease potentials via targeting cholinesterases, monoamine oxidases, glycogen synthase kinase-3, and Aβ aggregation
Asmaa E. Kassab, Ehab M. Gedawy, Alaa S. Sayed
International Journal of Biological Macromolecules (2024) Vol. 265, pp. 131018-131018
Closed Access | Times Cited: 8
Identification of hCA I, hCA II, AChE and BChE Inhibitory Properties of Some Norcantharimide Derivatives; Molecular Docking, SAR and in silico ADME Studies
Leyla Polat Köse, Aytekin Köse
ChemistrySelect (2024) Vol. 9, Iss. 16
Closed Access | Times Cited: 1
New Heterostilbene and Triazole Oximes as Potential CNS-Active and Cholinesterase-Targeted Therapeutics
Milena Mlakić, Tena Čadež, Goran Šinko, et al.
(2024)
Open Access | Times Cited: 1
Synthesis and biological evaluation of novel aminoquinolines with an n-octyl linker: Impact of halogen substituents on C(7) or a terminal amino group on anticholinesterase and BACE1 activity
Ana Matošević, Marija Bartolić, Nikola Maraković, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 112, pp. 129928-129928
Closed Access | Times Cited: 1
Design, synthesis, biological activities, and evaluation of molecular docking‐dynamics studies of new thiosemicarbazones that may be effective against Alzheimer's disease
Neslihan Conger, Derya Osmani̇ye, Begüm Nurpelin Sağlık, et al.
Journal of Molecular Recognition (2023) Vol. 36, Iss. 12
Open Access | Times Cited: 3
Cholesterol Oxime Olesoxime Assessed as a Potential Ligand of Human Cholinesterases
Dora Kolić, Goran Šinko, Ludovic Jean, et al.
Biomolecules (2024) Vol. 14, Iss. 5, pp. 588-588
Open Access
New Heterostilbene and Triazole Oximes as Potential CNS-Active and Cholinesterase-Targeted Therapeutics
Milena Mlakić, Tena Čadež, Goran Šinko, et al.
Biomolecules (2024) Vol. 14, Iss. 6, pp. 679-679
Open Access
Derivatives of Amodiaquine as Potent Human Cholinesterases Inhibitors: Implication for Treatment of Alzheimer’s Disease
Ana Matošević, Dejan Opsenica, Marija Bartolić, et al.
Molecules (2024) Vol. 29, Iss. 22, pp. 5357-5357
Open Access
Evaluation of hydrazone and N -acylhydrazone derivatives of vitamin B6 and pyridine-4-carbaldehyde as potential drugs against Alzheimer’s disease
Marija Bartolić, Ana Matošević, Nikola Maraković, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access
Profiling Novel Quinuclidine-Based Derivatives as Potential Anticholinesterase Drugs: Enzyme Inhibition and Effects on Cell Viability
Suzana Žunec, Donna Vadlja, Alma Ramić, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 155-155
Open Access | Times Cited: 1
Page 1

Scroll to top